India Glycols Limited announces hearing for scheme of arrangement on May 21, 2026
India Glycols Limited has announced a hearing for a Company Scheme Petition on May 21, 2026. The hearing is related to a Scheme of Arrangement involving India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited. The National Company Law Tribunal (NCLT) has scheduled this hearing.
This is a routine regulatory filing providing notice of a hearing for a corporate scheme. It does not immediately impact the company's financials or operations.
The announcement is a procedural update regarding a legal hearing for a scheme of arrangement and does not contain any financial performance indicators or operational news that would influence sentiment.
India Glycols Limited has submitted newspaper clippings regarding a Notice of Hearing for a Company Scheme Petition. The hearing is scheduled to take place on 21st May, 2026, as per the directions of the Hon'ble National Company Law Tribunal, Allahabad Bench, Prayagraj. This notice was published on 5th May, 2026, in the Financial Express, Business Standard, and Uttar Ujala newspapers.
The petition, filed under Sections 230 to 232 of the Companies Act, 2013, pertains to a Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited, including their respective shareholders. The National Company Law Tribunal (NCLT) had admitted the petition and scheduled the hearing date.
This announcement is an official notification to the stock exchanges, BSE Limited and National Stock Exchange of India Limited, detailing the upcoming legal proceeding related to the company's corporate restructuring.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.